Related Experiment Video
Updated: Jul 2, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Carnosine [corrected] increases efficiency of DOPA therapy of Parkinson's disease: a pilot study
Alexander Boldyrev1, Tatiana Fedorova, Maria Stepanova
1Research Center of Neurology, Russian Academy of Medical Sciences, Moscow, Russia. aaboldyrev@mail.ru
Abstract:
The addition of the neuropeptide carnosine (beta-alanyl-L-histidine) as a food additive to the basic protocol of Parkinson's disease treatment results in significant improvement of neurological symptoms, along with increase in red blood cell Cu/Zn-SOD and decrease in blood plasma protein carbonyls and lipid hydroperoxides, with no noticeable change in platelets MAO B activity. The combination of carnosine with basic therapy may be a useful way to increase efficiency of PD treatment.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Alterations in Muscle Tone lll
Neural Regulation
